1 3-formulation systems preparations
•
0 likes•184 views
This document discusses various topics related to formulation systems of pharmaceutical preparations including types of dosage forms, dosage form design, drug delivery systems, routes of drug administration, pharmaceutical ingredients, pharmacy compounding, and compounding and dispensing. It was written by Dr. L.T.M. Muungo and covers formulation considerations, compounding to meet unique needs, and designing dosage forms.
Report
Share
Report
Share
Download to read offline
Recommended
Phar1101 Drug Information Sources
Developed for PHAR1101 to support their Drug Pioneer assessment research. Provides a brief introduction to four specialist drug databases.
Assignment on pharmacy information resources
Pharmacy information resources and classification of them
Pharmacy Information Resources
Pharmacy information resources: The medical and pharmaceutical journals, review journals, periodicals, bulletins and books containing specific and particular information and theory about drug molecules are termed 'pharmacy information resources'.
Classification of Pharmacy Resources
There are a lot of sources from where we can get the information of all types of drugs.
Primary source of drug information
Secondary source
Special information
Pharmaceutical database
WHO Bulletin and journals
Drug directory
Physicians' desk reference
Text books of Pharmacy and pharmacology
Handouts of the pharmaceutical manufacturers
Pharmacy Information Resources
Pharmacy information resources: The medical and pharmaceutical journals, review journals, periodicals, bulletins and books containing specific and particular information and theory about drug molecules are termed 'pharmacy information resources'.
Classification of Pharmacy Resources
There are a lot of sources from where we can get the information of all types of drugs.
Primary source of drug information
Secondary source
Special information
Pharmaceutical database
WHO Bulletin and journals
Drug directory
Physicians' desk reference
Text books of Pharmacy and pharmacology
Handouts of the pharmaceutical manufacturers
Hospitals
Course - Diploma in Pharmacy
Subject - Hospital and Clinical Pharmacy
Topic: Hospital
For More Educational Resources visit to YouTube Channel: https://www.youtube.com/channel/UCCZaj-OnTx1n8JZKuBlJJcg
Website: https://amarskulkarni.wordpress.com
Hospital formulary
The hospital formulary is a continuously revised compilation of pharmaceutical dosage agent and their forms etc. which reflects the current clinical judgment of the medical staff.
Recommended
Phar1101 Drug Information Sources
Developed for PHAR1101 to support their Drug Pioneer assessment research. Provides a brief introduction to four specialist drug databases.
Assignment on pharmacy information resources
Pharmacy information resources and classification of them
Pharmacy Information Resources
Pharmacy information resources: The medical and pharmaceutical journals, review journals, periodicals, bulletins and books containing specific and particular information and theory about drug molecules are termed 'pharmacy information resources'.
Classification of Pharmacy Resources
There are a lot of sources from where we can get the information of all types of drugs.
Primary source of drug information
Secondary source
Special information
Pharmaceutical database
WHO Bulletin and journals
Drug directory
Physicians' desk reference
Text books of Pharmacy and pharmacology
Handouts of the pharmaceutical manufacturers
Pharmacy Information Resources
Pharmacy information resources: The medical and pharmaceutical journals, review journals, periodicals, bulletins and books containing specific and particular information and theory about drug molecules are termed 'pharmacy information resources'.
Classification of Pharmacy Resources
There are a lot of sources from where we can get the information of all types of drugs.
Primary source of drug information
Secondary source
Special information
Pharmaceutical database
WHO Bulletin and journals
Drug directory
Physicians' desk reference
Text books of Pharmacy and pharmacology
Handouts of the pharmaceutical manufacturers
Hospitals
Course - Diploma in Pharmacy
Subject - Hospital and Clinical Pharmacy
Topic: Hospital
For More Educational Resources visit to YouTube Channel: https://www.youtube.com/channel/UCCZaj-OnTx1n8JZKuBlJJcg
Website: https://amarskulkarni.wordpress.com
Hospital formulary
The hospital formulary is a continuously revised compilation of pharmaceutical dosage agent and their forms etc. which reflects the current clinical judgment of the medical staff.
Hospital formulary
Definition, contents of hospital formulary, Differentiation of hospital formulary and Drug list, preparation and revision, and addition and deletion of a drug from hospital formulary.
Drug formulary INDIA
It is very important to incorporate clinically relevant practicals into the undergraduate pharmacology practical (UGPP) curriculum. Various medical colleges in the state of Gujarat have included clinical practicals in their UGPP curriculum. [2] Rai has recommended the inclusion of the 'P-drug' concept in the UGPP curriculum.
The conference of experts on the rational use of drugs, convened by the World Health Organization in Nairobi in 1985, stated that: "Rational use of drugs requires that patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements for an adequate period of time, at the lowest cost to them and their community." This goal can be achieved by acquiring knowledge of the principles of rational drug usage during undergraduate training. This correspondence emphasizes the importance of this concept.
» What is a P-drug?
The drugs you are going to prescribe regularly and with which you will become familiar are called P(ersonal)-drugs. The P-drug concept includes the name of a drug, dosage form, dosage schedule and duration of treatment for a specified condition. Due to varying availability and cost of drugs, different national formularies and essential drug lists, medical culture and individual interpretation of information, P-drugs differ from country to country and between doctors.
There are four reasons that indicate why a P-drug should never be the one that has been suggested or dictated by clinical teachers, senior colleagues or by sales representatives: a) the latest and the most expensive drug is not necessarily the best, the safest or the most cost-effective, b) by developing one's own set of P-drugs, one can learn to handle pharmacological concepts and drug-related data in an effective manner, c) by compiling one's own set of P-drugs, one can prescribe alternatives when the P-drug cannot be used and d) one has the final responsibility for his / her patient's well being, which he / she cannot pass on to others. While physicians can and should draw on expert opinion and consensus guidelines, they should always think for themselves.
» Example for selecting a P-drug for acute amoebic dysentery Top
Amoebiasis is one of the common infections encountered in clinical practice and it is relatively easy to understand the pathophysiology as well as the treatment of amoebiasis. Therefore, we have selected the example of acute amoebic dysentery and analyzed it in consultation with standard textbooks of pharmacology.
Hospital Formulary
Pharmacy Practice for Final Year B.Pharmacy Sem-VII,
As per PCI Syllabus
Hospital Formulary
32. Development vector of regulatory procedures of biological medicines in Ru...
32. Development vector of regulatory procedures of biological medicines in Ru...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Provides an overview of the development of biotherapeutic & biosimilar regulations in Russia.Preformulation
Presentation cover
Introduction of Preformulation
Goals of Preformulation
Usefulness of Preformulation
Classes of Preformulation
Factors to be consider before Preformulation
Steps in Preformulation
Principle area of Preformulation
Evaluated parameters in Preformulation
Conclusion
Investigator's bronchure & investigational medicinal product dossier (IB & IM...
Investigator's bronchure & investigational medicinal product dossier (ib & impd) Naveen Balaji
What is a compounding pharmacy
Compounding Pharmacy (also referred to as compounding and pharmaceutical compounding) is a particular type of pharmacy that specializes in preparing a specific drug product in order to fill a patient's unique prescription.
Bioavailability study
The amount of drug that reaches the systemic circulation is called systemic availability.
It is a Primary stage of development of a suitable dosage form.
More Related Content
What's hot
Hospital formulary
Definition, contents of hospital formulary, Differentiation of hospital formulary and Drug list, preparation and revision, and addition and deletion of a drug from hospital formulary.
Drug formulary INDIA
It is very important to incorporate clinically relevant practicals into the undergraduate pharmacology practical (UGPP) curriculum. Various medical colleges in the state of Gujarat have included clinical practicals in their UGPP curriculum. [2] Rai has recommended the inclusion of the 'P-drug' concept in the UGPP curriculum.
The conference of experts on the rational use of drugs, convened by the World Health Organization in Nairobi in 1985, stated that: "Rational use of drugs requires that patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements for an adequate period of time, at the lowest cost to them and their community." This goal can be achieved by acquiring knowledge of the principles of rational drug usage during undergraduate training. This correspondence emphasizes the importance of this concept.
» What is a P-drug?
The drugs you are going to prescribe regularly and with which you will become familiar are called P(ersonal)-drugs. The P-drug concept includes the name of a drug, dosage form, dosage schedule and duration of treatment for a specified condition. Due to varying availability and cost of drugs, different national formularies and essential drug lists, medical culture and individual interpretation of information, P-drugs differ from country to country and between doctors.
There are four reasons that indicate why a P-drug should never be the one that has been suggested or dictated by clinical teachers, senior colleagues or by sales representatives: a) the latest and the most expensive drug is not necessarily the best, the safest or the most cost-effective, b) by developing one's own set of P-drugs, one can learn to handle pharmacological concepts and drug-related data in an effective manner, c) by compiling one's own set of P-drugs, one can prescribe alternatives when the P-drug cannot be used and d) one has the final responsibility for his / her patient's well being, which he / she cannot pass on to others. While physicians can and should draw on expert opinion and consensus guidelines, they should always think for themselves.
» Example for selecting a P-drug for acute amoebic dysentery Top
Amoebiasis is one of the common infections encountered in clinical practice and it is relatively easy to understand the pathophysiology as well as the treatment of amoebiasis. Therefore, we have selected the example of acute amoebic dysentery and analyzed it in consultation with standard textbooks of pharmacology.
Hospital Formulary
Pharmacy Practice for Final Year B.Pharmacy Sem-VII,
As per PCI Syllabus
Hospital Formulary
32. Development vector of regulatory procedures of biological medicines in Ru...
32. Development vector of regulatory procedures of biological medicines in Ru...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Provides an overview of the development of biotherapeutic & biosimilar regulations in Russia.Preformulation
Presentation cover
Introduction of Preformulation
Goals of Preformulation
Usefulness of Preformulation
Classes of Preformulation
Factors to be consider before Preformulation
Steps in Preformulation
Principle area of Preformulation
Evaluated parameters in Preformulation
Conclusion
Investigator's bronchure & investigational medicinal product dossier (IB & IM...
Investigator's bronchure & investigational medicinal product dossier (ib & impd) Naveen Balaji
What is a compounding pharmacy
Compounding Pharmacy (also referred to as compounding and pharmaceutical compounding) is a particular type of pharmacy that specializes in preparing a specific drug product in order to fill a patient's unique prescription.
Bioavailability study
The amount of drug that reaches the systemic circulation is called systemic availability.
It is a Primary stage of development of a suitable dosage form.
What's hot (18)
Cadth 2015 c6 final- hospital formularies decision-making process es
Cadth 2015 c6 final- hospital formularies decision-making process es
32. Development vector of regulatory procedures of biological medicines in Ru...
32. Development vector of regulatory procedures of biological medicines in Ru...
Investigator's bronchure & investigational medicinal product dossier (IB & IM...
Investigator's bronchure & investigational medicinal product dossier (IB & IM...
More from University of Zambia, School of Pharmacy, Lusaka, Zambia
More from University of Zambia, School of Pharmacy, Lusaka, Zambia (20)
Recently uploaded
Toxic effects of heavy metals : Lead and Arsenic
Heavy metals are naturally occuring metallic chemical elements that have relatively high density, and are toxic at even low concentrations. All toxic metals are termed as heavy metals irrespective of their atomic mass and density, eg. arsenic, lead, mercury, cadmium, thallium, chromium, etc.
Seminar of U.V. Spectroscopy by SAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityUniversity of Rennes, INSA Rennes, Inria/IRISA, CNRS
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
Richard's aventures in two entangled wonderlands
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Nutraceutical market, scope and growth: Herbal drug technology
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
In this book, we use conservation of energy techniques on a fluid element to derive the Modified Bernoulli equation of flow with viscous or friction effects. We derive the general equation of flow/ velocity and then from this we derive the Pouiselle flow equation, the transition flow equation and the turbulent flow equation. In the situations where there are no viscous effects , the equation reduces to the Bernoulli equation. From experimental results, we are able to include other terms in the Bernoulli equation. We also look at cases where pressure gradients exist. We use the Modified Bernoulli equation to derive equations of flow rate for pipes of different cross sectional areas connected together. We also extend our techniques of energy conservation to a sphere falling in a viscous medium under the effect of gravity. We demonstrate Stokes equation of terminal velocity and turbulent flow equation. We look at a way of calculating the time taken for a body to fall in a viscous medium. We also look at the general equation of terminal velocity.
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits: A Revolutionary
Breakthrough in Sustainable Energy Science
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Orion Air Quality Monitoring Systems - CWS
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Recently uploaded (20)
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
DERIVATION OF MODIFIED BERNOULLI EQUATION WITH VISCOUS EFFECTS AND TERMINAL V...
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
1 3-formulation systems preparations
- 1. Formulation systems of pharmaceutical preparations • Types of Dosage Forms • Dosage Form Design • Drug Delivery System • Routes of Drug Administration • Pharmaceutical Ingredients (PIs) • Pharmacy Compounding • Compounding and Dispensing TYPES OF DOSAGE FORMS DRUG DELIVERY SYSTEMS Dr. L.T.M. Muungo, PhD Pharmacy Compounding Meeting unique physician and patient needs Dr. L.T. Muungo Compounding and Dispensing Dosage Form Design: Pharmaceutical and Formulation Considerations